Related Experiment Video
Updated: Feb 18, 2026
09:09
Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
8.8K
Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis
Fabian Schuler1, Johannes G Weiss1, Silke E Lindner1
1Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innrain 80, A-6020, Innsbruck, Austria.
Nature Communications
|November 24, 2017
Summary
Checkpoint kinase 1 (CHK1) is essential for B-cell development and survival. Inhibiting CHK1 triggers apoptosis in B-cells, highlighting its potential as a therapeutic target for blood cancers.
Area of Science:
- Molecular Biology
- Cancer Biology
- Immunology
Background:
- Checkpoint kinase 1 (CHK1) regulates cell cycle control and DNA damage response.
- CHK1's role in cancer therapy has been explored, with initial studies suggesting a tumor suppressor function.
- Its specific involvement in B-cell biology and lymphomagenesis remained less understood.
Purpose of the Study:
- To elucidate the role of CHK1 in normal B-cell development.
- To investigate CHK1's function in lymphomagenesis and B-cell survival.
- To assess the therapeutic potential of CHK1 inhibition in blood cancers.
Main Methods:
- Utilized chemical CHK1 inhibition in primary and malignant B-cells.
- Employed Chk1 haploinsufficient and ablated mouse models.
- Analyzed B-cell development, lymphomagenesis timing, and apoptosis pathways (including BCL2 and mitochondrial apoptosis).
Main Results:
- Chemical CHK1 inhibition induced BCL2-dependent apoptosis in B-cells.
- CHK1 expression levels influenced the timing of lymphomagenesis in mice.
- Complete Chk1 ablation in B-cells arrested development at the pro-B cell stage, with cell cycle arrest overriding apoptosis.
- This arrest served as a mechanism to prevent the spread of damaged DNA.
Conclusions:
- CHK1 is indispensable for normal B-cell development.
- CHK1 plays a critical role in B-cell survival and lymphomagenesis.
- Targeting CHK1 represents a promising strategy for treating blood cancers.
Related Concept Videos
02:15M-Cdk Drives Transition Into Mitosis
6.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.6K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
01:31The Intrinsic Apoptotic Pathway
8.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
01:20The JAK-STAT Signaling Pathway
13.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.2K
01:07MAPK Signaling Cascades
8.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.7K
02:38Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K